RBC Retains OR Royalties' Outperform Rating, US$56 Price Target

-- RBC Capital Markets on Tuesday maintained OR Royalties' (OR.TO) outperform rating and US$56 price target.

Singapore-based Boroo has announced it had entered into an exclusivity agreement to potentially acquire the previously operating Eagle gold mine in Yukon from its receiver, PwC. OR maintains a 5% net smelter royalty on the mine.

In June 2024, a catastrophic heap leach failure occurred at the Eagle mine, leading to environmental damage. OR acquired the Eagle royalty in March 2018 for C$98 million.

"We note that no final agreement is in place, and key hurdles to production advancement include rehabilitation of the mine's prior heap leach failure as well as local First Nations approval," RBC said.

RBC added that Boroo is currently in default of its streaming obligation at the ATO operation to stream holder Triple Flag Precious Metals (TFPM.TO).

OR traded at US$36.82 per share at last look Wednesday on the New York Stock Exchange.

Price: $50.72, Change: $-0.74, Percent Change: -1.44%

瑞银表示，星巴克将保持销售增长势头，下半年将重点关注利润率。

瑞银周三在一份报告中指出，星巴克 (SBUX) 有望在其转型战略的推动下保持强劲的销售势头，但投资者关注的焦点正转向下半年的利润率复苏。瑞银表示，第二季度强劲的交易驱动型同店销售增长反映了运营改善、菜单创新和更新的会员计划。展望未来，瑞银表示，持续推进下午饮品平台、会员计划升级、门店关闭和运营改进等举措应能支撑下半年的销售增长。瑞银还预计，在销售杠杆、成本节约以及关税和咖啡成本压力缓解的推动下，星巴克的利润率将在今年晚些时候有所提升。瑞银将星巴克的目标股价从100美元上调至105美元，但维持“中性”评级。Price: $106.10, Change: $+8.82, Percent Change: +9.06%

$SBUX

Wedbush将Biogen的目标股价从191美元上调至196美元，理由是“催化引擎正在加速运转”，并维持中性评级。

根据FactSet调查的分析师报告，百健（BIIB）的平均评级为“增持”，平均目标价为213.79美元。（报道北美、亚洲和欧洲主要银行及研究机构的股票、商品和经济研究。研究机构可通过以下链接联系我们：https://www..com/contact-us）Price: $195.08, Change: $+11.70, Percent Change: +6.38%

$BIIB

RBC Retains OR Royalties' Outperform Rating, US$56 Price Target

相关文章

瑞银表示，星巴克将保持销售增长势头，下半年将重点关注利润率。

美国银行证券上调评级后，Elevance Health股价上涨

Wedbush将Biogen的目标股价从191美元上调至196美元，理由是“催化引擎正在加速运转”，并维持中性评级。